Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Xanomeline/Trospium
Locations
1
United States
Clinical Site
Richmond, Texas, United States
Start Date
April 16, 2025
Primary Completion Date
October 30, 2026
Completion Date
November 30, 2026
Last Updated
April 11, 2025
NCT06894212
NCT04226898
NCT05240976
NCT06745479
NCT07455929
NCT05304767
Lead Sponsor
Vanguard Research Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions